Brief: Immunogen Reports Recent Progress And 2022 Financial Results

ImmunoGen

01/03/2023 11:46

March 1 (Reuters) - Immunogen Inc  IMGN.O :
    * IMMUNOGEN REPORTS RECENT PROGRESS AND 2022 FINANCIAL
RESULTS
    * SEES 2023 REVENUES, EXCLUDING PRODUCT REVENUE FROM
ELAHERE,
BETWEEN $30 MILLION AND $35 MILLION
    * SEES 2023 OPERATING EXPENSES BETWEEN $310 MILLION AND $320
MILLION
    * Q4 EARNINGS PER SHARE VIEW $-0.30, REVENUE VIEW $17.3
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $117.7 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBwcdg6rJa 
Further company coverage:  IMGN.O